Skip to content

Author

Wen-Xing Jiang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Synergistic Anti‐Tumor Effect of Chidamide and Linperlisib on Natural Killer/T‐Cell Lymphoma by Inhibiting PI3K/AKT/mTOR Pathway

Natural killer/T‐cell lymphoma (NKTCL) is an aggressive lymphoma subtype with limited treatment options, especially for relapsed or refractory patients. Chidamide, a histone deacetylase inhibitor, and linperlisib, a phosphatidylinositol‐3‐kinase (PI3K) inhibitor, have shown promise in treating peripheral T‐cell lymphom...

Wen-Xing Jiang, Zhuang-Zhuang Shi, Zhao-Ming Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.